Markey and Manchin urge FDA to stop its study of opioids for chronic pain
Markey and Manchin: “Other studies have already evaluated prolonged opioid use without biasing the outcome or exposing patients to risk.”
Two Democratic senators are warning the Food and Drug Administration not to proceed with a controversial trial meant to measure opioids’ effectiveness as a chronic pain treatment.
In a letter shared with STAT, Sens. Ed Markey (D-Mass.) and Joe Manchin (D-W.Va.) warned FDA Commissioner Robert Califf against using the method in the agency’s ongoing work to evaluate whether opioids, despite their widespread use, are effective at treating chronic pain.
What's Your Reaction?
